SpringWorks Therapeutics, Inc. (SWTX) Ownership

$46.23

north_east
$0.02 (0.04%)
Day's range
$46.18
Day's range
$46.3

SpringWorks Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/13/2025 11.16 M $403.14 M   0.15% 15.02%
VANGUARD GROUP INC 02/11/2025 7.16 M $258.65 M   6.64% 9.64%
BLACKROCK, INC. 02/07/2025 5.96 M $215.35 M   0.31% 8.03%
DEEP TRACK CAPITAL, LP 02/14/2025 3.46 M $125.04 M   -9.97% 4.66%
02/14/2025 3.42 M $123.62 M   100.00% 4.61%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 3.27 M $118.32 M   -6.87% 4.41%
STATE STREET CORP 02/14/2025 3.00 M $108.43 M   -2.90% 4.04%
MAVERICK CAPITAL LTD 02/14/2025 2.89 M $104.48 M   4.09% 3.89%
PICTET ASSET MANAGEMENT HOLDING SA 02/12/2025 2.39 M $86.40 M   24.17% 3.22%
CAPITAL INTERNATIONAL INVESTORS 02/13/2025 2.36 M $85.33 M   92.69% 3.18%
MORGAN STANLEY 02/14/2025 2.00 M $72.16 M   38.83% 2.69%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.67 M $60.36 M   0.00% 2.25%
ECOR1 CAPITAL, LLC 02/14/2025 1.56 M $56.36 M   100.00% 2.10%
POLAR CAPITAL HOLDINGS PLC 02/14/2025 1.50 M $54.20 M   0.00% 2.02%
ARROWMARK COLORADO HOLDINGS LLC 02/14/2025 1.50 M $54.16 M   0.47% 2.02%
WOODLINE PARTNERS LP 02/14/2025 1.49 M $53.84 M   7.85% 2.01%
SIREN, L.L.C. 02/14/2025 1.38 M $49.78 M   0.00% 1.86%
ORBIMED ADVISORS LLC 02/14/2025 1.26 M $45.34 M   -9.75% 1.69%
FIERA CAPITAL CORP 01/29/2025 1.22 M $44.05 M   -3.08% 1.64%
PRINCIPAL FINANCIAL GROUP INC 01/31/2025 1.10 M $39.88 M   20.19% 1.49%
GW&K INVESTMENT MANAGEMENT, LLC 02/05/2025 974.39 K $35.20 M   5.30% 1.31%
AMERIPRISE FINANCIAL INC 02/14/2025 971.10 K $35.09 M   21.71% 1.31%
LORD, ABBETT & CO. LLC 02/14/2025 945.81 K $34.17 M   -11.59% 1.27%
DUQUESNE FAMILY OFFICE LLC 02/14/2025 859.69 K $31.06 M   21.93% 1.16%
VOYA INVESTMENT MANAGEMENT LLC 05/02/2025 796.68 K $28.78 M   9.27% 1.07%
02/14/2025 764.67 K $27.63 M   100.00% 1.03%
FINEPOINT CAPITAL LP 02/13/2025 748.75 K $27.05 M   15.04% 1.01%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 717.71 K $25.93 M   -1.02% 0.97%
NORTHERN TRUST CORP 02/14/2025 655.68 K $23.69 M   8.78% 0.88%
VICTORY CAPITAL MANAGEMENT INC 02/06/2025 614.92 K $22.22 M   -2.30% 0.83%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 605.25 K $21.87 M   0.50% 0.82%
SOROS FUND MANAGEMENT LLC 02/14/2025 600.47 K $21.69 M   7.36% 0.81%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 02/12/2025 592.65 K $21.41 M   -7.86% 0.80%
INVESCO LTD. 02/13/2025 557.07 K $20.13 M   6.16% 0.75%
BANK OF AMERICA CORP /DE/ 02/14/2025 416.89 K $15.06 M   -51.59% 0.56%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 407.68 K $14.73 M   42.77% 0.55%
D. E. SHAW & CO., INC. 02/14/2025 387.73 K $14.01 M   -46.50% 0.52%
CITADEL ADVISORS LLC 02/14/2025 373.23 K $13.48 M   185.55% 0.50%
NEW YORK STATE COMMON RETIREMENT FUND 01/31/2025 364.06 K $13.15 M   0.00% 0.49%
GOLDMAN SACHS GROUP INC 02/11/2025 339.92 K $12.28 M   -19.41% 0.46%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 328.91 K $11.88 M   64.57% 0.44%
RAYMOND JAMES FINANCIAL INC 04/23/2025 291.36 K $10.53 M   100.00% 0.39%
ORACLE INVESTMENT MANAGEMENT INC 02/14/2025 254.77 K $9.20 M   644.95% 0.34%
JPMORGAN CHASE & CO 02/12/2025 227.94 K $8.24 M   -10.63% 0.31%
UBS GROUP AG 02/14/2025 222.18 K $8.03 M   64.97% 0.30%
BANK OF NEW YORK MELLON CORP 02/04/2025 195.94 K $7.08 M   -13.65% 0.26%
SCHONFELD STRATEGIC ADVISORS LLC 02/14/2025 194.04 K $7.01 M   -2.63% 0.26%
SEGALL BRYANT & HAMILL, LLC 02/11/2025 193.46 K $6.99 M   43.37% 0.26%
NORGES BANK 02/12/2025 186.50 K $6.74 M   100.00% 0.25%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 02/14/2025 185.52 K $6.70 M   100.00% 0.25%

SpringWorks Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 221 institutional investors and hedge funds held shares of SpringWorks Therapeutics, Inc.. The most heavily invested institutionals were:

M&T BANK CORP: 0

PRIVATE TRUST CO NA: 0

FMR LLC: 11.16 M

VANGUARD GROUP INC: 7.16 M

Deep Track Capital, LP: 3.46 M

PRICE T ROWE ASSOCIATES INC /MD/: 3.27 M

108.90% of SpringWorks Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 78.01 M shares in the last 24 months. This purchase volume represents approximately $3.61 B in transactions.